Status:
UNKNOWN
Intra-arterial Chemotherapy for Children With Retinoblastoma
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Retinoblastoma
Eligibility:
All Genders
6-10 years
Phase:
PHASE1
PHASE2
Brief Summary
Retinoblastoma is a cancer of the eye that occurs exclusively in children. The treatment for retinoblastoma may include surgery, chemotherapy, radiation and local treatments to the eye such as freezin...
Eligibility Criteria
Inclusion
- Children with retinoblastoma in a single remaining eye with useful vision
Exclusion
- None
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00906113
Start Date
June 1 2011
End Date
December 1 2017
Last Update
October 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah University Hospital
Jerusalem, Israel, 91120